000128367 001__ 128367
000128367 005__ 20240228135054.0
000128367 0247_ $$2doi$$a10.1002/pmic.201300320
000128367 0247_ $$2pmid$$apmid:24610664
000128367 0247_ $$2altmetric$$aaltmetric:2208411
000128367 037__ $$aDKFZ-2017-04384
000128367 041__ $$aeng
000128367 082__ $$a540
000128367 1001_ $$0P:(DE-HGF)0$$aSrinivasan, Harish$$b0$$eFirst author
000128367 245__ $$aPrediction of recurrence of non muscle-invasive bladder cancer by means of a protein signature identified by antibody microarray analyses.
000128367 260__ $$aWeinheim$$bWiley VCH55771$$c2014
000128367 3367_ $$2DRIVER$$aarticle
000128367 3367_ $$2DataCite$$aOutput Types/Journal article
000128367 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1521638431_922
000128367 3367_ $$2BibTeX$$aARTICLE
000128367 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000128367 3367_ $$00$$2EndNote$$aJournal Article
000128367 520__ $$aAbout 70% of newly diagnosed cases of bladder cancer are low-stage, low-grade, non muscle-invasive. Standard treatment is transurethral resection. About 60% of the tumors will recur, however, and in part progress to become invasive. Therefore, surveillance cystoscopy is performed after resection. However, in the USA and Europe alone, about 54 000 new patients per year undergo repeated cystoscopies over several years, who do not experience recurrence. Analysing in a pilot study resected tumors from patients with (n = 19) and without local recurrence (n = 6) after a period of 5 years by means of an antibody microarray that targeted 724 cancer-related proteins, we identified 255 proteins with significantly differential abundance. Most are involved in the regulation and execution of apoptosis and cell proliferation. A multivariate classifier was constructed based on 20 proteins. It facilitates the prediction of recurrence with a sensitivity of 80% and a specificity of 100%. As a measure of overall accuracy, the area under the curve value was found to be 91%. After validation in additional sample cohorts with a similarly long follow-up, such a signature could support decision making about the stringency of surveillance or even different treatment options.
000128367 536__ $$0G:(DE-HGF)POF3-312$$a312 - Functional and structural genomics (POF3-312)$$cPOF3-312$$fPOF III$$x0
000128367 588__ $$aDataset connected to CrossRef, PubMed,
000128367 650_7 $$2NLM Chemicals$$aProteome
000128367 7001_ $$aAllory, Yves$$b1
000128367 7001_ $$0P:(DE-He78)45440b44791309bd4b7dbb4f73333f9b$$aSill, Martin$$b2$$udkfz
000128367 7001_ $$aVordos, Dimitri$$b3
000128367 7001_ $$0P:(DE-He78)db487558e84f68cf9bf0496497be50f7$$aAlhamdani, Mohamed Saiel Saeed$$b4$$udkfz
000128367 7001_ $$aRadvanyi, Francois$$b5
000128367 7001_ $$0P:(DE-He78)c684a26e52cc44716354a4d15f530b4e$$aHoheisel, Jörg$$b6$$udkfz
000128367 7001_ $$0P:(DE-He78)886719d32ffd20859eb73f286b799b2d$$aSchröder, Christoph$$b7$$eLast author$$udkfz
000128367 773__ $$0PERI:(DE-600)2253166-X$$a10.1002/pmic.201300320$$gVol. 14, no. 11, p. 1333 - 1342$$n11$$p1333 - 1342$$tPractical proteomics$$v14$$x1615-9853$$y2014
000128367 909CO $$ooai:inrepo02.dkfz.de:128367$$pVDB
000128367 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000128367 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)45440b44791309bd4b7dbb4f73333f9b$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000128367 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)db487558e84f68cf9bf0496497be50f7$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000128367 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)c684a26e52cc44716354a4d15f530b4e$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000128367 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)886719d32ffd20859eb73f286b799b2d$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000128367 9131_ $$0G:(DE-HGF)POF3-312$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunctional and structural genomics$$x0
000128367 9141_ $$y2014
000128367 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bPROTEOMICS : 2015
000128367 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000128367 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000128367 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000128367 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000128367 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000128367 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000128367 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000128367 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000128367 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000128367 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000128367 9201_ $$0I:(DE-He78)C060-20160331$$kC060$$lBiostatistik$$x0
000128367 9201_ $$0I:(DE-He78)B070-20160331$$kB070$$lFunktionelle Genomanalyse$$x1
000128367 980__ $$ajournal
000128367 980__ $$aVDB
000128367 980__ $$aI:(DE-He78)C060-20160331
000128367 980__ $$aI:(DE-He78)B070-20160331
000128367 980__ $$aUNRESTRICTED